X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2566) 2566
Publication (382) 382
Patent (141) 141
Newspaper Article (106) 106
Book Review (26) 26
Book Chapter (12) 12
Newsletter (5) 5
Dissertation (3) 3
Conference Proceeding (2) 2
Government Document (2) 2
Streaming Video (2) 2
Trade Publication Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1772) 1772
mutation (1675) 1675
humans (1569) 1569
animals (865) 865
hematology (654) 654
proteins (636) 636
female (500) 500
male (491) 491
oncology (434) 434
genetic aspects (430) 430
myeloproliferative neoplasms (430) 430
calreticulin (417) 417
mice (412) 412
cell biology (403) 403
research (378) 378
calreticulin - genetics (376) 376
essential thrombocythemia (370) 370
biochemistry & molecular biology (356) 356
mutations (349) 349
polycythemia-vera (338) 338
tumors (336) 336
endoplasmic reticulum (329) 329
janus kinase 2 - genetics (321) 321
middle aged (309) 309
endoplasmic-reticulum (308) 308
endoplasmic reticulum - metabolism (298) 298
myelofibrosis (296) 296
biochemistry (289) 289
analysis (285) 285
adult (284) 284
gene expression (283) 283
aged (269) 269
research article (269) 269
cancer (259) 259
jak2 (246) 246
gene mutations (245) 245
multidisciplinary sciences (242) 242
signal transduction (242) 242
protein folding (236) 236
medicine (235) 235
leukemia (232) 232
apoptosis (224) 224
genes (214) 214
article (209) 209
myeloproliferative disorders - genetics (209) 209
diagnosis (205) 205
microbiology (202) 202
phenotype (202) 202
expression (198) 198
physiological aspects (197) 197
science (197) 197
health aspects (195) 195
kinases (195) 195
biology (194) 194
immunology (193) 193
thrombocythemia, essential - genetics (190) 190
mutation - genetics (188) 188
amino acid sequence (187) 187
cell line (186) 186
primary myelofibrosis - genetics (186) 186
prognosis (183) 183
molecular sequence data (182) 182
peptides (182) 182
primary myelofibrosis (180) 180
genetics & heredity (175) 175
chemistry (169) 169
disease (167) 167
protein (163) 163
gene (162) 162
protein binding (155) 155
aged, 80 and over (154) 154
cells (152) 152
patients (150) 150
genetics (148) 148
risk factors (147) 147
somatic mutations (147) 147
care and treatment (146) 146
enzymology (145) 145
protein transport (143) 143
tyrosine kinase jak2 (143) 143
beer (141) 141
metallurgy (141) 141
mutation or genetic engineering (141) 141
spirits (141) 141
vinegar (141) 141
wine (141) 141
janus kinase 2 (139) 139
receptors, thrombopoietin - genetics (135) 135
review (135) 135
bone marrow (134) 134
thrombosis (131) 131
calreticulin - metabolism (130) 130
abridged index medicus (128) 128
neurosciences (128) 128
medicine, research & experimental (126) 126
life sciences (125) 125
glycosylation (124) 124
identification (124) 124
stem cells (123) 123
culture media (120) 120
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2803) 2803
French (61) 61
German (21) 21
Russian (9) 9
Chinese (8) 8
Danish (4) 4
Hungarian (4) 4
Japanese (4) 4
Spanish (3) 3
Hebrew (2) 2
Portuguese (2) 2
Turkish (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 25, pp. 2379 - 2390
Journal Article
Blood, ISSN 0006-4971, 03/2016, Volume 127, Issue 10, pp. 1325 - 1335
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2018, Volume 181, Issue 6, pp. 791 - 802
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e56387
Background: Calreticulin, a Ca2+-buffering chaperone of the endoplasmic reticulum, is highly expressed in the heart and is essential for cardiac development.... 
CALSEQUESTRIN | HYPERTROPHY | MULTIDISCIPLINARY SCIENCES | CARDIAC MYOCYTES | CALCIUM-RELEASE | GENE-EXPRESSION | ENDOPLASMIC-RETICULUM STRESS | SARCOPLASMIC-RETICULUM | HUMAN HEART | MODULATION | TRANSGENIC MICE | Cardiomyopathy, Dilated - pathology | Calsequestrin - genetics | RNA, Messenger - metabolism | Myosin Heavy Chains - metabolism | Promoter Regions, Genetic - genetics | Myocardium - metabolism | Ultrasonography | Calreticulin - metabolism | Electrocardiography | Sarcoplasmic Reticulum - metabolism | Calsequestrin - metabolism | Calcium Signaling | Cardiomyopathy, Dilated - genetics | Down-Regulation | Mice, Inbred C57BL | RNA, Messenger - genetics | Connexins - genetics | Mice, Transgenic | Myocardium - pathology | Organ Specificity | Cardiomyopathy, Dilated - metabolism | Connexins - metabolism | Cardiomyopathy, Dilated - diagnostic imaging | Animals | Chickens | Mice | Heart failure | Heart | Cardiomyopathy | Analysis | Genetic engineering | Calcium-binding proteins | Cardiology | Heart diseases | Pediatrics | Biochemistry | Connexin 43 | Ca2+-transporting ATPase | Calcium signalling | Proteins | Embryogenesis | Calreticulin | Sarcoplasmic reticulum | Transgenic animals | Rodents | Calcium buffering | Physiology | Calsequestrin | Mitral valve | Echocardiography | Cardiac muscle | Materials handling | Transgenic mice | Cardiomyocytes | Pharmacology | Anatomy & physiology | Gene expression | Medicine | Pathology | Dilated cardiomyopathy | Mutation | Ventricle | Laboratory animals | Endoplasmic reticulum | Adenosine triphosphatase | Calcium (reticular)
Journal Article
Leukemia, ISSN 0887-6924, 02/2018, Volume 32, Issue 2, pp. 429 - 437
The calreticulin (CALR) exon 9 mutations are found in similar to 30% of patients with essential thrombocythemia and primary myelofibrosis. Recently, we... 
POLYCYTHEMIA-VERA | ONCOLOGY | GENES | CLASS-I | NEOANTIGENS | ESSENTIAL THROMBOCYTHEMIA | HEMATOLOGY | INTERFERON-ALPHA THERAPY | T-CELLS | CHRONIC MYELOPROLIFERATIVE NEOPLASMS | Exons - drug effects | Humans | Primary Myelofibrosis - immunology | HLA Antigens - immunology | Exons - genetics | Male | Vaccines, Subunit - immunology | HLA Antigens - genetics | Mutation - genetics | Thrombocythemia, Essential - genetics | Calreticulin - genetics | CD4-Positive T-Lymphocytes - immunology | Neoplasms - therapy | Phenotype | Primary Myelofibrosis - genetics | Vaccines, Subunit - therapeutic use | Mutation - drug effects | Neoplasms - genetics | Neoplasms - immunology | Thrombocythemia, Essential - immunology | HLA Antigens - drug effects | Aged | Cytotoxicity, Immunologic - drug effects | CD4-Positive T-Lymphocytes - drug effects | Usage | Gene mutations | Immunotherapy | Genetic aspects | Research | T cells | Health aspects | Cancer | Cell culture | Therapy | Target recognition | Toxicity | Vaccination | Cytotoxicity | Lymphocytes T | Hematopoietic stem cells | Cell recognition | Calreticulin | Lymphocytes | Autografts | Phenotypes | Myelofibrosis | Immune response | Epitopes | Patients | CD4 antigen | White blood cells | Monocytes | Dilution | Stem cells | Degranulation | Histocompatibility antigen HLA | Mutation | Human behavior
Journal Article
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 11/2014, Volume 99, Issue 11, pp. 1697 - 1700
We tested 357 Chinese with primary myelofibrosis for mutations in CALR, JAK2 and MPL. CALR mutations were detected in 76 subjects (21%). There were 24 (32%)... 
MYELOPROLIFERATIVE NEOPLASMS | DISORDERS | JAK2 | HEMATOLOGY | Primary Myelofibrosis - mortality | Primary Myelofibrosis - diagnosis | Prognosis | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Janus Kinase 2 - genetics | Male | Calreticulin - genetics | Young Adult | Primary Myelofibrosis - genetics | China | Adolescent | Aged, 80 and over | Adult | Female | Aged | Mutation
Journal Article